Best Patient Panel Providers in South Korea for Clinical & Market Research
Compare top patient panel providers in South Korea for 2026. Get expert insights on verified clinical research, patient recruitment, and data quality standards.
Quick answer
For large-scale clinical data and commercial strategy, IQVIA; for deep qualitative expert insights, M3 Global Research; for custom recruitment and complex patient journey mapping, Global Vox Populi; for broad market sentiment across the general population, Dynata.
Selecting the right partner among patient panel providers in South Korea is a high-stakes task for pharmaceutical and clinical research leads. In a market where digital adoption is high but regulatory requirements for health data are strict, the ability to source verified, compliant, and deeply profiled respondents is the primary factor in research success.
This assessment evaluates eight providers active in South Korea, focusing on their ability to deliver accurate data for clinical development and market access. Whether you require rare-disease patient access or physician-level intelligence for launch readiness, understanding the distinction between generalist panels and healthcare-specialized networks is necessary to make sure your findings are actionable for the local market.
Best Patient Panel Providers in South Korea for Clinical & Market Research: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Complex patient and caregiver research | 89.0 |
| 2 | IQVIA | Large-scale clinical trial recruitment | 86.0 |
| 3 | M3 Global Research | Physician and specialist engagement | 83.5 |
| 4 | Ipsos | Global healthcare trend analysis | 81.0 |
| 5 | Dynata | High-volume quantitative survey data | 78.0 |
| 6 | Hankook Research | Local South Korean market intelligence | 71.0 |
| 7 | InVeritas Research | Hard-to-reach professional recruitment | 68.0 |
| 8 | BioNixus | Account-level healthcare data | 66.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | Patients, caregivers, physicians, healthcare professionals | Identity validation, license checks, and rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 1,150,843 patient profiles; 24,100 caregivers (in South Korea; Global Vox Populi panel records, Oct 2026) | Not published |
| IQVIA | Physicians, patients, healthcare decision-makers | Internal site and data validation protocols | Not stated on pages reviewed | Not published | Not published | Not published |
| M3 Global Research | Physicians, healthcare professionals | Verification of medical credentials and registrations | Not stated on pages reviewed | Project quote | 2M+ physicians and healthcare professionals (m3globalresearch.com, Oct 2026) | Not published |
| Ipsos | Patients, physicians, healthcare professionals | Authenticated proprietary panelist systems | Not stated on pages reviewed | Not published | Not published | Not published |
| Dynata | Patients, caregivers, healthcare professionals | Multi-layered verification system and ML fraud detection | Not stated on pages reviewed | Project quote / Self-serve | 70M+ global panelists (dynata.com, Oct 2026) | Not published |
| Hankook Research | Physicians, pharmacists, consumers | Internal panel authentication and credential checks | Not stated on pages reviewed | Project quote | Not published | Not published |
| InVeritas Research | Physicians, business decision-makers | Internal quality control and credential checks | Not stated on pages reviewed | Project quote | Not published | Not published |
| BioNixus | Physicians, payers, hospital decision-makers | Identity and quality checks on every project wave | Not stated on pages reviewed | Project quote | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| IQVIA | ● | – | – | ● | – | ● |
| M3 Global Research | ● | ● | ● | ● | ● | ● |
| Ipsos | ● | ● | ● | ● | – | ● |
| Dynata | ● | ● | ● | ● | ● | ● |
| Hankook Research | ● | ● | ● | ● | – | – |
| InVeritas Research | ● | ● | – | ● | ● | – |
| BioNixus | ● | ● | – | ● | ● | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their ability to deliver verifiable clinical data and compliant patient access in the South Korean market.
| Criterion | Weight | What it means here |
|---|---|---|
| Sample Quality and Verification | 25 | This criterion measures how providers recruit and authenticate panelists. In South Korea, high-quality providers must verify patient conditions and physician credentials through direct registry cross-referencing. A strong score reflects a provider that owns its proprietary panel and performs active validation, rather than relying on open-market sample exchanges that may contain duplicate or fraudulent entries. |
| Compliance, Certifications and Security | 20 | This reflects the provider’s adherence to international standards like ISO 9001 and ISO/IEC 27001, alongside local data protection requirements. Because health data carries significant sensitivity, good performance here requires transparent consent management and established protocols for adverse event reporting. Providers must demonstrate a clear commitment to protecting respondent privacy throughout the entire fieldwork lifecycle. |
| Target Audience Reach | 15 | Reach evaluates the depth of the provider's panel within specific therapeutic areas and its capacity for low-incidence recruitment. In South Korea, effective providers must go beyond general populations to offer granular segmentation of patients and healthcare professionals. Success is defined by the ability to access hard-to-reach groups, such as patients with rare conditions or specific caregiver roles. |
| Data Quality and Fraud Prevention | 10 | This assesses the technical controls in place to maintain data integrity, such as device fingerprinting, geo-location checks, and trap questions. Given the prevalence of automated bot activity, top-tier providers in South Korea deploy multi-layered detection systems that remove low-quality or fraudulent completes before data is delivered to the client, making sure results are statistically valid. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This criterion evaluates the range of research methods offered, including online surveys, telephone interviews, and qualitative approaches like focus groups or ethnography. A capable provider offers the flexibility to switch between quantitative and qualitative modes to suit the specific clinical or market objective, making sure researchers can capture both broad trends and deep behavioral insights. |
| Client Service and Speed | 5 | This scores the provider’s ability to manage projects efficiently, from initial proposal to data delivery. In the fast-paced South Korean market, a high score indicates a team that provides proactive communication, rapid turnaround on feasibility requests, and effective problem-solving during the fieldwork phase, making sure that researchers meet their critical project milestones. |
| Pricing and Feasibility Transparency | 5 | Transparency in pricing and feasibility involves providing clear, upfront estimates on what is achievable within a given timeframe. High-scoring firms provide honest assessments of sample availability and incidence rates, avoiding the temptation to over-promise. This allows project managers to plan their research budgets and timelines with confidence, reducing the risk of mid-study delays. |
Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: patient panel providers in South Korea
Global Vox Populi: best for complex patient and caregiver research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitResearchers requiring deep, verifiable patient and caregiver data for clinical or commercial development in South Korea.
Global Vox Populi provides international research services supported by its own proprietary panels. In South Korea, the company maintains a dedicated patient panel and a specialized caregivers panel to support clinical and market research needs.
The firm operates with a focus on data integrity, using internal validation processes to protect respondent quality. Its presence in the South Korean market includes the capability to conduct both qualitative and quantitative studies across 27 therapeutic areas, offering deep access for researchers needing specific patient profiles.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Patient panel, in South Korea
1,150,843 patient profiles
- Aesthetics & Cosmetic369,820
- Cardiovascular88,046
- Ophthalmology67,475
- Endocrinology & Metabolic65,127
- Dermatology56,942
- Women's Health53,238
Across 731 conditions; a patient with more than one condition is counted once per condition.
Caregivers panel, in South Korea
24,100 panellists
- Spouse / Partner5,597
- Adult Child > Parent/Elderly8,211
- Parent > Child w/ Condition1,958
- Sibling1,223
- Grandchild <> Grandparent1,071
- Other Family1,458
Scorecard: 89.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 89.0 |
Core services
- Proprietary Panel Access: Access to a patient panel in South Korea comprising over 1.1 million profiles across multiple therapeutic areas.
- Caregiver Research: Specialized caregivers panel in South Korea with over 24,000 members segmented by their specific relationship to the patient.
- Healthcare Professional Access: Verified access to healthcare professionals across 70+ specialties, including physicians, nurses, and allied health professionals.
Strengths
- Deep Patient Segmentation: Provides granular access to over 1.1 million patient profiles in South Korea, including significant reach in oncology, dermatology, and metabolic conditions.
- Rigorous Data Validation: Employs multi-layered quality controls, including device fingerprinting and identity verification, to make sure that every patient and caregiver participant is authentic.
- Compliance and Security: Operates under ISO 9001, 20252, and 27001 certifications, making sure that all health data is handled according to strict privacy and security protocols.
Innovation and technology
- Advanced Quality Scoring: Uses completion-quality scoring to filter out speeders and fraudulent completes before data delivery, protecting only high-quality insights reach the researcher.
- Proprietary Platform: All surveys are programmed and hosted on an internal platform, providing researchers with full control over the survey environment and respondent experience.
Impact on businesses
- Informed Clinical Decisions: Enables pharmaceutical and biotech companies to gather real-world evidence and patient perspectives to inform clinical trial design and commercial launch strategies.
- Market Access Strategy: Supports researchers in understanding patient journeys and payer dynamics, helping to shape effective market access and pricing strategies.
Why it may fit your brief
The provider is well-suited for briefs needing low-incidence recruitment or specific patient journey mapping due to its large proprietary panel. Other providers might be preferred for very broad, non-medical general population surveys.
IQVIA: best for large-scale clinical trial recruitment

Strongest fitGlobal pharmaceutical firms requiring large-scale clinical trial support and data-heavy market analytics.
IQVIA maintains a significant presence in South Korea, offering end-to-end clinical research and commercial strategy services. The firm integrates data, technology, and analytics to support pharmaceutical and biotech organizations throughout the product lifecycle.
Its operations in South Korea benefit from access to proprietary data and a global network of healthcare experts. The company specializes in clinical trial site identification and the optimization of clinical development processes through advanced modeling and predictive analytics.
Scorecard: 86.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 86.0 |
Core services
- Clinical Development: Full-service clinical trial solutions including site identification and patient recruitment strategies.
- Real-World Evidence: Generation of clinical insights using non-identified patient records and proprietary healthcare datasets.
- Commercial Strategy: Consulting and analytics services to support market access and commercial execution.
Strengths
- Data-Driven Insights: Access to petabytes of proprietary data and non-identified patient records to optimize clinical trial designs.
- Global Infrastructure: Extensive international footprint that allows for the scaling of clinical and commercial projects across multiple geographies.
- Specialized Expertise: Dedicated teams focused on biostatistics, medical writing, and pharmacovigilance to manage complex regulatory requirements.
Innovation and technology
- IQVIA.ai Platform: A unified agentic platform that connects data, technology, and analytics to optimize clinical trial decision-making.
- Predictive Modeling: Use of life science models to predict trial outcomes and improve the probability of success for new assets.
Impact on businesses
- Accelerated Innovation: Enables faster clinical trial site identification and execution, reducing the time required to bring new therapies to market.
- Optimized R&D Spend: Delivers efficiency in clinical trial operations by reducing screen-fail rates and improving patient retention.
Why it may fit your brief
IQVIA is ideal for complex clinical development projects where proprietary data and large-scale infrastructure are needed. For smaller, bespoke qualitative research projects, a boutique agency might offer more agility.
M3 Global Research: best for physician and specialist engagement

Strongest fitResearchers needing to access specific physician specialties and medical professionals for clinical or commercial studies.
M3 Global Research is a dedicated healthcare fieldwork provider with active operations in South Korea. The firm is part of the global M3 Group, which specializes in connecting with medical professionals.
The company focuses on providing high-quality recruitment and data collection services for pharmaceutical and life science organizations. Its panel comprises millions of verified physicians and healthcare professionals, making it a primary choice for clinical development insights.
Scorecard: 83.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | m3globalresearch.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 83.5 |
Core services
- Physician Recruitment: Access to a global panel of verified physicians for market research studies.
- Fieldwork Services: Comprehensive data collection, including online surveys and in-depth interviews.
- Healthcare Research Support: Support for clinical development and medical market research projects.
Strengths
- Verified Medical Panel: Large, verified panel of over 2 million physicians and healthcare professionals worldwide.
- Deep Healthcare Focus: Specialized emphasis on the healthcare space, protecting expertise in medical terminology and clinical contexts.
- Global Presence: Operations in 248 markets across 70 countries, supporting international research requirements.
Innovation and technology
- Professional Panel Management: Advanced management of physician panels to protect high engagement and data quality.
Impact on businesses
- Clinical Insights: Provides high-quality data to help pharmaceutical companies understand real-world medical practices.
- Expert Feedback: Enables clients to gather insights from highly specialized physicians, informing product development and market positioning.
Why it may fit your brief
M3 is ideal for accessing hard-to-reach medical specialists. For studies requiring a broad mix of patient, caregiver, and physician perspectives, a more diversified provider might be preferred.
Ipsos: best for global healthcare trend analysis

Strongest fitOrganizations needing to track long-term healthcare trends and brand perception across multiple markets.
Ipsos provides healthcare research solutions in South Korea, focusing on perceptions of healthcare systems and market trends. The company uses a mix of surveys, social media data, and qualitative research to deliver actionable insights.
Its healthcare division in South Korea works with pharmaceutical and life science clients to optimize commercial strategies. Ipsos emphasizes the use of science and technology to provide understanding of market and patient behaviors.
Scorecard: 81.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 81.0 |
Core services
- Healthcare Market Research: Custom primary research among doctors, nurses, and patients to support launch and commercial strategies.
- Brand Health Tracking: Continuous monitoring of brand performance and market positioning for healthcare clients.
- Qualitative Research: In-depth qualitative methodologies to understand the patient and physician experience.
Strengths
- Global Research Framework: Uses a consistent global approach to market research, allowing for comparable insights across international markets.
- Broad Methodological Range: Combines traditional survey data with social media analysis and qualitative techniques to provide a holistic view.
- Expertise in Perceptions: Strong capability in tracking healthcare system quality and public health trends, relevant for policy and market access research.
Innovation and technology
- AI-Driven Insights: Uses artificial intelligence to analyze large datasets and deliver faster, more accurate market understanding.
Impact on businesses
- Actionable Truth: Helps clients make informed decisions by transforming data into clear, strategic recommendations.
- Commercial Optimization: Supports pharmaceutical companies in refining their commercial strategies through better understanding of physician and patient needs.
Why it may fit your brief
Ipsos is well-positioned for large-scale tracking studies and perception research. For highly specific, small-scale clinical recruitment, a specialist clinical panel provider might be more effective.
Dynata: best for high-volume quantitative survey data

Strongest fitCompanies requiring large, statistically significant quantitative samples with high data integrity.
Dynata operates a significant first-party data platform in South Korea, providing access to verified patient, caregiver, and physician panels. The company caters to global life science firms needing multi-modal research capabilities.
The firm emphasizes data quality through its proprietary QualityScore model, which identifies and removes low-quality respondents. Dynata offers both self-serve and fully managed research engagements, allowing clients to balance speed and depth.
Scorecard: 78.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.0 |
Core services
- First-Party Data Access: Access to a global platform of deeply profiled consumers and business professionals.
- Managed Research Services: Full-service research design and execution, tailored to specific client objectives.
- Multi-Channel Sampling: Ability to recruit respondents via web, phone, SMS, and mail for diverse research needs.
Strengths
- QualityScore ML Model: Analyzes 175+ data points to filter out fraudulent or low-attention respondents in real-time.
- Extensive Reach: Access to millions of global panelists, providing the ability to reach even niche audiences at scale.
- Flexibility: Offers both self-serve platforms for rapid data collection and managed services for complex research designs.
Innovation and technology
- Conversational AI: Uses AI to follow up on open-ended questions, providing qualitative depth across quantitative samples.
- Dynata+: A self-serve research platform that allows for rapid scoping and launching of surveys.
Impact on businesses
- Efficient Data Collection: Reduces cleaning time and increases data accuracy, allowing clients to move from insight to action faster.
- Informed Marketing Decisions: Provides precise data to help clients optimize their marketing plans and brand impact.
Why it may fit your brief
Dynata is excellent for high-speed, high-volume quantitative studies. For specialized clinical projects requiring deep medical nuance, a healthcare-focused boutique firm may be more suitable.
Hankook Research: best for local South Korean market intelligence

Strongest fitCompanies looking for deep local market knowledge and established access to South Korean healthcare professionals.
Hankook Research is a prominent South Korean research agency with a long-standing reputation for marketing and opinion research. Its dedicated healthcare division provides research services for prescription drugs and medical devices.
The company maintains proprietary panels of physicians and pharmacists in South Korea, serving both local and international pharmaceutical clients. It integrates local market expertise with advanced research methodologies to support commercial strategies.
Scorecard: 71.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | hrc.co.kr (2 pages reviewed), Oct 2026 |
| Weighted score | 100 | 71.0 |
Core services
- Healthcare Research: Custom quantitative and qualitative research for pharmaceutical and medical device clients.
- Professional Panels: Proprietary panels of physicians and pharmacists specifically in the South Korean market.
- Market Intelligence: Analysis of medical service experiences and healthcare trends in South Korea.
Strengths
- Local Market Depth: Deep knowledge of the South Korean healthcare environment, including regulatory and cultural nuances.
- Professional Infrastructure: Access to proprietary panels of local physicians and pharmacists.
- Diverse Expertise: Capability to handle research across various industries, including healthcare, automotive, and technology.
Innovation and technology
- Advanced Observational Tools: Uses VR simulators and remote monitoring equipment for specialized research projects.
Impact on businesses
- Strategic Decision Support: Provides reliable data to help companies shape their marketing strategies and understand public opinion in South Korea.
- Product Development Insights: Supports clients in developing products that meet the specific needs of the South Korean market.
Why it may fit your brief
Hankook Research is a strong choice for projects requiring high local cultural and regulatory sensitivity. For global projects spanning many countries, a firm with a larger international network might be more efficient.
InVeritas Research: best for hard-to-reach professional recruitment

Strongest fitCompanies needing to conduct complex qualitative research among specialized professional audiences.
InVeritas Research provides quantitative and qualitative market research services with a focus on healthcare and B2B sectors. The firm operates across South Korea, offering fieldwork services for diverse healthcare needs.
The company is known for its ability to recruit hard-to-reach audiences, including specialized physicians and business decision-makers. It follows strict quality control procedures to protect the reliability of its findings.
Scorecard: 68.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 68.0 |
Core services
- Healthcare Research: Specialized qualitative and quantitative studies for medical devices, diagnostics, and pharmaceutical companies.
- B2B Market Research: Research among business decision-makers and high-net-worth individuals.
- Qualitative Services: Expertise in focus groups, in-depth interviews, and ethnographic research.
Strengths
- Niche Audience Recruitment: Extensive experience in researching hard-to-reach audiences, including subspecialty physicians.
- Quality Control: Dedicated quality control team that monitors project execution at every step.
- Methodological Flexibility: Ability to design bespoke research programs using a wide range of methodologies, including face-to-face and digital.
Innovation and technology
- Bespoke Research Design: Customizes research instruments and approaches to address unique brand and market issues.
Impact on businesses
- Commercial Insights: Enables stakeholders with real-world data to take commercially sound and bold decisions.
- Market Leadership: Helps brands outperform in their target markets by uncovering hidden market truths.
Why it may fit your brief
InVeritas is well-suited for niche B2B and specialized healthcare recruiting. For projects requiring massive, automated quantitative samples, a platform-based provider might be more appropriate.
BioNixus: best for account-level healthcare data

Strongest fitMarketing and commercial teams needing granular, account-level performance data for specific product launches.
BioNixus is a global market research firm with a specialized healthcare division in South Korea. The company focuses on account-level and SKU-level brand versus competitor data, filling gaps left by traditional syndicated feeds.
The firm provides primary research services for pharmaceutical and medical device clients, including market sizing, pricing, and launch readiness studies. It emphasizes the use of locally-based teams to protect high-quality fieldwork and regulatory alignment.
Scorecard: 66.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 66.0 |
Core services
- Account-Level Research: Primary market research designed to provide granular brand versus competitor data at the account level.
- Healthcare Strategy: Consulting services including market sizing, pricing, and HTA dossier development.
- Physician Surveys: Statistically solid quantitative and qualitative research among physicians and hospital decision-makers.
Strengths
- Granular Data: Provides account-level and SKU-level performance data that traditional syndicated subscriptions often miss.
- Decision-Ready Outputs: Delivers decision packs designed for commercial directors, rather than just raw data exports.
- Regulatory Expertise: Deep understanding of local regulatory and payer environments to support HTA and market access decisions.
Innovation and technology
- Primary Data Focus: Prioritizes primary research over template-based reporting to answer specific commercial questions.
Impact on businesses
- Launch Readiness: Helps pharmaceutical companies improve launch strategies by providing clear insights into hospital and channel dynamics.
- Portfolio Prioritization: Enables leadership teams to convert primary evidence into clear decisions on portfolio priority and market expansion.
Why it may fit your brief
BioNixus is ideal for targeted commercial research where syndicated data is insufficient. For broad, general public opinion research, other firms with larger consumer panels would be better choices.
How patient panel verification actually works in South Korea
Protect your provider uses multi-step verification including license checks and identity fingerprinting to maintain clinical data integrity.
Professional Credential Verification
For studies involving physicians or specialized healthcare professionals, providers should cross-reference participant information against national medical registries or license databases. In South Korea, this is essential to prevent fraudulent participation. Ask your provider for their specific process for validating professional status during the registration and re-validation phases. If a provider cannot explain how they confirm a doctor’s specialty or license status, consider that a significant risk to the validity of your clinical data.
Patient Condition Authentication
Validating that a patient actually has a specific medical condition is difficult but necessary. Good providers use screening questions that focus on treatment history, medication usage, or hospital visit records to confirm eligibility. You should request to see the screening logic used for your project. Be wary of providers who rely solely on self-reported survey answers without secondary validation or historical data checks, as these are often prone to inaccuracies that can undermine your findings.
Identity and Fraud Prevention
Advanced providers employ device fingerprinting and geo-location tracking to make sure participants are who they claim to be and are located in the target region. These technical measures help detect bots and repeat respondents who attempt to register multiple times. During your procurement process, ask for proof of these systems and how they handle detected fraud. A reliable partner will provide clear evidence of their quality control metrics, including bounce rates and the percentage of completes removed for fraud.
Caregiver Validation
When researching caregivers, providers should use targeted screening to confirm the relationship to the patient and the level of care provided. This may involve validating the patient’s condition or the care setting. Because this group is often harder to reach, providers should have specific protocols for verifying the nature of the caregiver relationship. Protect your provider uses specific questions to define the caregiver’s role, rather than generic screening that might capture individuals who do not meet your research criteria.
How to choose the right provider in South Korea
Select a provider based on the specific depth of their healthcare panel and their ability to verify clinical credentials.
- Assess Panel Ownership: Prioritize providers that own their proprietary patient and physician panels. This ownership allows for better control over data quality and makes sure the provider has a direct relationship with the respondents.
- Verify Local Expertise: Make sure the provider has a dedicated team in South Korea that understands the local healthcare system and regulatory requirements. Cultural and linguistic nuance is essential for high-quality qualitative research.
- Review Quality Controls: Demand transparency regarding the provider’s fraud detection and data validation processes. A good provider will have clear, documented procedures for identifying and filtering out low-quality responses.
- Check Compliance Standards: Make sure the firm holds relevant ISO certifications and follows strict data privacy laws. Protecting health data is non-negotiable in pharmaceutical research.
- Evaluate Methodological Fit: Choose a provider whose research methods align with your project goals. A firm specializing in deep qualitative interviews may not be the best fit for a massive quantitative tracking study.
Questions to ask before you commission
- What specific methods do you use to verify that a patient participant has the required medical condition?
- How often do you re-validate the credentials of the physicians in your South Korean panel?
- Can you provide a breakdown of your patient panel size by specific therapeutic area in South Korea?
- What technical controls do you have in place to prevent bot and fraudulent activity during survey fielding?
- How do you protect compliance with both international health data standards and local Korean privacy regulations?
- What is your process for managing and reporting adverse events during healthcare research studies?
Common pitfalls to avoid
- Ignoring Panel Source: Relying on generalist panels that aggregate sample from third-party sources often leads to poor data quality and unreliable medical insights.
- Overlooking Local Nuance: Assuming that global research templates will work perfectly in South Korea without local adaptation can result in missed cultural or regulatory insights.
- Neglecting Data Validation: Failing to verify the credentials of medical professionals can lead to the inclusion of unqualified respondents in your research data.
- Focusing Only on Price: Prioritizing the lowest cost per complete often results in higher project risks, such as poor-quality data or the need for expensive re-fielding.
What a feasibility check should include
A thorough feasibility check should include a detailed breakdown of reachable sample sizes by specific therapeutic area and respondent type.
Sample Depth Check
A proper feasibility check must include specific counts for your target patient or physician segment in South Korea, not just a total panel size. This makes sure the provider truly has the reach required for your specific therapeutic area.
Incidence Rate Validation
Ask the provider for their estimated incidence rate for your target group. An honest provider will provide a realistic estimate rather than promising an overly optimistic timeline that may lead to failure.
Timeline Realism
Make sure the feasibility report includes a clear, phased project timeline. This helps manage stakeholder expectations and allows for adjustments in recruitment strategy if early fielding results are lower than expected.
Regulatory Assessment
A good feasibility study will also identify any potential regulatory or compliance hurdles for your specific study type in South Korea. This proactive approach saves time and reduces project risk.
Conclusion
Choosing between patient panel providers in South Korea requires a balance of reach, verification, and regulatory compliance. For large-scale clinical development projects, partners with extensive infrastructure and deep medical data are often the most efficient choice. For specialized, qualitative insights or niche patient recruitment, boutique agencies that focus on proprietary panels offer greater control and data integrity.
Use the provided scorecard to evaluate each provider against your specific needs. Prioritize firms that demonstrate verifiable panel ownership and transparent quality control metrics. By focusing on these factors, you can make sure that your research produces high-quality, actionable insights that meet both clinical and commercial objectives in the South Korean market.
Planning research in South Korea? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
How do I recruit patients for clinical trials in South Korea?
Clinical trial recruitment in South Korea is typically managed through partnerships with established healthcare research providers or CROs. These firms use their proprietary panels to identify eligible patients based on specific clinical criteria, making sure that recruitment follows strict regulatory and ethical guidelines. It is essential to work with a provider that verifies patient medical history and makes sure that all recruitment processes align with local ethics committee requirements.
Which market research firms have the largest physician panels in South Korea?
Several firms have significant physician panels in South Korea, including global organizations like IQVIA and M3 Global Research, which maintain large, verified networks of medical professionals. Boutique firms like Hankook Research also offer specialized local panels. The best choice depends on whether you require a global network for international consistency or deep local expertise for specific South Korean medical practices.
Are there English-speaking patient panel providers in Seoul?
Yes, many of the leading research providers in Seoul operate with bilingual teams to support international pharmaceutical and biotech clients. Most firms offering global research services provide project management and report delivery in English. When selecting a provider, confirm their capability to handle both English-language study materials and Korean-language respondent interactions to protect data accuracy and participant understanding.
What are the best healthcare market research agencies in Korea?
The best agency depends on your project goals. Global leaders like IQVIA and Ipsos are well-suited for large-scale clinical and commercial strategy studies. Specialized firms like M3 Global Research and BioNixus excel in physician and account-level research. For complex patient and caregiver recruitment, firms like Global Vox Populi provide deep proprietary panel access. Evaluate them based on your specific needs for data depth, methodology, and local market reach.
How do I conduct patient experience surveys in Korean hospitals?
Conducting patient experience surveys in Korean hospitals requires careful planning and compliance with hospital-level regulations. You should partner with a research agency that has experience working through the local healthcare environment and obtaining the necessary approvals. These agencies can implement surveys via various methods, including online, telephone, or in-person, making sure that the respondent experience is appropriate for the hospital setting and that data collection meets all privacy standards.
What is the regulatory process for healthcare market research in South Korea?
Healthcare market research in South Korea must adhere to strict data privacy and clinical research regulations. This includes compliance with the Personal Information Protection Act and, for clinical studies, guidance from the Ministry of Food and Drug Safety. A professional research provider will manage the regulatory process, including obtaining necessary consents and making sure that all data collection practices meet local ethical and legal standards.
How do I protect data quality for healthcare surveys in South Korea?
Data quality is maintained through multi-layered validation. This includes using verified proprietary panels rather than open-market samples, implementing device and identity fingerprinting to detect fraud, and using trap questions to identify speeders. Always ask your provider for their specific quality control SOPs and evidence of how they filter out low-quality completes before delivering the final dataset to your team.
Why is proprietary panel ownership important for healthcare research?
Proprietary panel ownership allows the research provider to maintain a direct relationship with respondents, protecting higher data quality and better profiling. Unlike rented panels from third-party exchanges, proprietary panels are managed under the provider’s own quality standards, including regular verification of professional credentials and medical history. This consistency reduces the risk of fraud and makes sure that the research data is based on authentic, well-qualified participants.